GlycoVaxyn
About:
GlycoVaxyn develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology.
Website: http://www.glycovaxyn.com/
Top Investors: Index Ventures, Edmond de Rothschild Private Equity, Sofinnova Partners
Description:
GlycoVaxyn AG, a vaccine biopharmaceutical company, develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology. It develops and produces immunogenic glycoprotein conjugates vaccines for a range of bacterial diseases, such as pneumococcal and nosocomial infections.
$34.3M
Schlieren, Zurich, Switzerland
2004-01-01
11-50
2010-05-04
Private
© 2025 bioDAO.ai